OVID THERAPEUTICS INC (OVID) Stock Analyst Earnings Estimates
NASDAQ:OVID - Nasdaq - US6904691010 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 208.4M 1,553.97% | 1.5M -99.28% | 391.7K -73.89% | 671.293K 71.38% | 374.85K -44.16% | 22.845M 5,994.44% | 2.737M -88.02% | 22.024M 704.68% | 91.713M 316.42% | 252.31M 175.11% | 396.37M 57.10% | 305.31M -22.97% | |
| EBITDA YoY % growth | 124.4M 253.39% | -55M -144.21% | -58.713M -6.75% | -64.602M -10.03% | -58.65M 9.21% | -53.876M 8.14% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 124.2M 252.58% | -55.5M -144.69% | -59.281M -6.81% | -64.851M -9.39% | -49.049M 24.37% | -27.638M 43.65% | -76.704M -177.53% | -76.102M 0.79% | 30.303M 139.82% | 193.85M 539.71% | 298.52M 54.00% | N/A | |
| Operating Margin | 59.60% | -3,700.00% | -15,134.40% | -9,660.55% | -13,084.84% | -120.98% | -2,802.48% | -345.54% | 33.04% | 76.83% | 75.31% | N/A | |
| EPS YoY % growth | 2.03 245.00% | -0.77 -137.93% | -0.75 2.60% | -0.41 44.80% | -0.67 -61.39% | -0.41 38.84% | -0.74 -82.23% | -0.88 -17.81% | -0.87 1.16% | -0.66 23.53% | 0.56 184.62% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.17 23.04% | -0.15 11.20% | -0.16 -229.41% | -0.16 20.57% | -0.15 9.84% | -0.11 25.68% | 0.01 106.57% | -0.12 22.95% | 0.01 106.68% |
| Revenue Q2Q % growth | 193.076K 35.97% | 114.75K -22.47% | 119.85K -29.08% | 119.85K -30.72% | 102K -47.17% | 71.4K -37.78% | 8.925M 7,346.81% | 20.4K -82.98% | 8.874M 8,600.00% |
| EBITDA Q2Q % growth | -13.585M 22.90% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -13.298M 26.89% | -12.596M 27.68% | -12.7M 38.10% | -13.314M -0.67% | -14.704M -10.58% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.20 -25.00% | -0.21 | 0.01 | 3.83% |
| Q2 2024 Q2Q % growth | 0.12 166.67% | -0.23 | 0.35 | 152.99% |
| Q1 2024 Q2Q % growth | -0.17 10.53% | -0.22 | 0.05 | 23.51% |
| Q4 2023 Q2Q % growth | -0.22 -37.50% | -0.05 | -0.17 | -333.89% |
| Q3 2023 Q2Q % growth | -0.16 5.88% | -0.19 | 0.03 | 16.83% |
| Q2 2023 Q2Q % growth | -0.18 14.29% | -0.21 | 0.03 | 13.75% |
| Q1 2023 Q2Q % growth | -0.19 17.39% | -0.17 | -0.02 | -8.77% |
| Q4 2022 Q2Q % growth | -0.16 -60.00% | -0.19 | 0.03 | 13.93% |
| Q3 2022 Q2Q % growth | -0.17 | -0.22 | 0.05 | 22.21% |
| Q2 2022 Q2Q % growth | -0.21 8.70% | -0.25 | 0.04 | 17.23% |
| Q1 2022 Q2Q % growth | -0.23 -109.09% | -0.21 | -0.02 | -8.80% |
| Q4 2021 Q2Q % growth | -0.10 70.59% | -0.16 | 0.06 | 39.20% |
| Q3 2021 Q2Q % growth | -0.17 39.29% | -0.19 | 0.02 | 9.30% |
| Q2 2021 Q2Q % growth | -0.23 43.90% | -0.17 | -0.06 | -39.19% |
| Q1 2021 Q2Q % growth | 2.53 783.78% | 1.71 | 0.82 | 47.80% |
| Q4 2020 Q2Q % growth | -0.34 2.86% | -0.32 | -0.02 | -7.58% |
| Q3 2020 Q2Q % growth | -0.28 34.88% | -0.37 | 0.09 | 24.14% |
| Q2 2020 Q2Q % growth | -0.41 -20.59% | -0.36 | -0.05 | -12.77% |
| Q1 2020 Q2Q % growth | -0.37 19.57% | -0.34 | -0.03 | -9.38% |
| Q4 2019 Q2Q % growth | -0.35 | -0.42 | 0.07 | 16.10% |
| Q3 2019 Q2Q % growth | -0.43 | -0.37 | -0.06 | -15.93% |
| Q2 2019 Q2Q % growth | -0.34 | -0.44 | 0.10 | 22.84% |
| Q1 2019 Q2Q % growth | -0.46 | -0.43 | -0.03 | -6.15% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 173K 58.76% | 88.883K | 84.117K | 94.64% |
| Q2 2024 Q2Q % growth | 169K 125.33% | 71.4K | 97.6K | 136.69% |
| Q1 2024 Q2Q % growth | 148K 123.70% | 60.761K | 87.239K | 143.58% |
| Q4 2023 Q2Q % growth | 142K | 57.63K | 84.37K | 146.40% |
| Q3 2023 Q2Q % growth | 108.97K | 51K | 57.97K | 113.67% |
| Q2 2023 Q2Q % growth | 75K | 48.705K | 26.295K | 53.99% |
| Q1 2023 Q2Q % growth | 66.16K -95.27% | 19.043K | 47.117K | 247.42% |
| Q1 2022 Q2Q % growth | 1.4M -99.33% | 1.4M | % | |
| Q4 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | 208.4M | 123.05M | 85.35M | 69.36% |
| Q4 2020 Q2Q % growth | 5.7M | 4.248M | 1.452M | 34.18% |
| Q3 2020 Q2Q % growth | 6.9M | 84.997K | 6.815M | 8,017.97% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.34% | 10.69% | 0% | 6.76% |
| Revenue | -1.24% | 215.48% | -0.19% | 41.04% |